RE: IPO19 Nov 2020 19:58
Spot on Davide. Here's the extract from the RNA:
In addition, should the DHSC allow the supply of AbC-19™ Rapid tests to third party customers, the terms of this contract will apply between the consortium members.
Under the agreement, Abingdon Health will undertake its own manufacturing with Omega and BBI Solutions Ltd also manufacturing and supplying AbC-19™ Rapid tests to Abingdon Health. CIGA Healthcare Ltd will carry out assembly services. Omega will manufacture not less than 25% of the demand from total orders placed, either from the UK Government or, where allowed, third party customers.
Key bit is: not less than 25%. The more ODX can muster the better. In addition we have our own antibody test too. Which will also be sold to meet demand.